Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Current Leases: 2019-2024

Historic Current Leases for Nutex Health (NUTX) over the last 5 years, with FY2024 value amounting to $7.7 million.

  • Nutex Health's Current Leases rose 3509.56% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 3509.56%. This contributed to the annual value of $7.7 million for FY2024, which is 7852.26% up from last year.
  • Nutex Health's Current Leases amounted to $7.7 million in FY2024, which was up 7852.26% from $4.3 million recorded in FY2023.
  • Nutex Health's Current Leases' 5-year high stood at $7.7 million during FY2024, with a 5-year trough of $1.5 million in FY2021.
  • Over the past 4 years, Nutex Health's median Current Leases value was $4.3 million (recorded in 2022), while the average stood at $4.4 million.
  • Its Current Leases has fluctuated over the past 5 years, first surged by 18318.97% in 2022, then skyrocketed by 228.61% in 2023.
  • Over the past 4 years, Nutex Health's Current Leases (Annual) stood at $1.5 million in 2021, then surged by 183.19% to $4.2 million in 2022, then increased by 2.29% to $4.3 million in 2023, then skyrocketed by 78.52% to $7.7 million in 2024.
  • Its Current Leases was $7.7 million in FY2024, compared to $4.3 million in FY2023 and $4.2 million in FY2022.